Literature DB >> 19343100

Cyclooxygenase products and atherosclerosis.

Macrae F Linton1, Sergio Fazio.   

Abstract

Entities:  

Year:  2008        PMID： 19343100      PMCID： PMC2630286          DOI： 10.1016/j.ddstr.2008.05.006

Source DB:  PubMed          Journal:  Drug Discov Today Ther Strateg        ISSN： 1740-6773


× No keyword cloud information.
  111 in total

1.  Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.

Authors:  Miao Wang; Alicia M Zukas; Yiqun Hui; Emanuela Ricciotti; Ellen Puré; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

Review 2.  Balancing prostanoid activity in the human vascular system.

Authors:  Nicholas A Flavahan
Journal:  Trends Pharmacol Sci       Date:  2007-02-05       Impact factor: 14.819

3.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

Review 4.  Cyclooxygenase-2 inhibition and coagulation.

Authors:  Jan Steffel; Thomas F Lüscher; Frank Ruschitzka; Felix C Tanner
Journal:  J Cardiovasc Pharmacol       Date:  2006       Impact factor: 3.105

5.  Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.

Authors:  J K Hennan; J Huang; T D Barrett; E M Driscoll; D E Willens; A M Park; L J Crofford; B R Lucchesi
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

6.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.

Authors:  Francesco Cipollone; Elena Toniato; Stefano Martinotti; Maria Fazia; Annalisa Iezzi; Chiara Cuccurullo; Barbara Pini; Sebastiano Ursi; Gianfranco Vitullo; Maurizio Averna; Marcello Arca; Anna Montali; Filomena Campagna; Sante Ucchino; Francesco Spigonardo; Stefano Taddei; Agostino Virdis; Giovanni Ciabattoni; Alberto Notarbartolo; Franco Cuccurullo; Andrea Mezzetti
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

8.  Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.

Authors:  Orina A Belton; Angela Duffy; Sinead Toomey; Desmond J Fitzgerald
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

9.  Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.

Authors:  Peter Bogaty; James M Brophy; Martin Noel; Luce Boyer; Serge Simard; Fernand Bertrand; Gilles R Dagenais
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

Review 10.  Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2.

Authors:  Annaleise V Sampey; Seetha Monrad; Leslie J Crofford
Journal:  Arthritis Res Ther       Date:  2005-04-06       Impact factor: 5.156
View more
  6 in total

1.  Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study.

Authors:  Maria S Govorkova; Tatyana Milman; Gui-Shuang Ying; Wei Pan; Rona Z Silkiss
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 May/Jun       Impact factor: 1.746

2.  Role of endothelium-dependent hyperpolarisation and prostacyclin in diabetes.

Authors:  Siti Safiah Mokhtar; Aida Hanum Ghulam Rasool
Journal:  Malays J Med Sci       Date:  2015 Mar-Apr

3.  Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.

Authors:  Roya Kelishadi
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

4.  Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis.

Authors:  Vladimir R Babaev; Joshua D Chew; Lei Ding; Sarah Davis; Matthew D Breyer; Richard M Breyer; John A Oates; Sergio Fazio; Macrae F Linton
Journal:  Cell Metab       Date:  2008-12       Impact factor: 27.287

5.  Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking.

Authors:  A Yeong Lee; Joo-Youn Lee; Jin Mi Chun
Journal:  Plants (Basel)       Date:  2020-12-10

6.  Lipid metabolism patterns and relevant clinical and molecular features of coronary artery disease patients: an integrated bioinformatic analysis.

Authors:  Yanhui Liao; Zhenzhen Dong; Hanhui Liao; Yang Chen; Longlong Hu; Zuozhong Yu; Yi Xia; Yuanbin Zhao; Kunpeng Fan; Jingwen Ding; Xiongda Yao; Tianhua Deng; Renqiang Yang
Journal:  Lipids Health Dis       Date:  2022-09-10       Impact factor: 4.315
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.